{"name":"Corino Therapeutics, Inc.","slug":"corino-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPeVYybjhPS3BDWWhVN1JpOG1FYWJrRVNXT3JuZHUtby1xQ0FrcUdvM1RRcGVtX3MzanhsbUVlNDF4bkcyWV9YU0d0a3NmY2RFc0hza2p2enpCZVBjdElXRU1NUFNRRHZWSnJ2MVJzUjJreVZXVUpZR2dIaWxTWTQ5SmpxcWlJOXp1TkN0dkRNTzZ2M1FueEhfN2M5bW40MUtDWUlIaFJLZHF0d190TU9pUWJYOHFoemZGNUw1LThFbTdzSmxDUFFYX2Z4TDdlY1NmRk5KeDczY253T1A2Y0tPLXgyQkZlek4wYWZrY09wYjJPeUFIY0R1cg?oc=5","date":"2025-10-08","type":"pipeline","source":"PR Newswire","summary":"Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New Treatment Launches | DelveInsight - PR Newswire","headline":"Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New Treatment Launches | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOVEJRbFlxSjJaUEpjNmJ1VzR1cVhMNmpzSXRZVmdPSjd6Ylc0T3hvODg3WkNGMVdQa1pKUFRST0lDbTl6Z0lGbm1lWnhoMll2aGVyMHpXZjJQN2ZTLVZqS19fdkhuVGRxUDdaaU42dnFrUWlFUUZicWUtZE4xbEphVmdwQm85MDVCcnJ4dzdoWUppZldzNW8yODdXMDNPSXptWWNrUWg0QWNOVUhtbHZETVNkZjRyVWhDOGpRS0QtR3d3MDZXTTFlaVRybnphUXpUejNMa0UxS3Z3V2Nm?oc=5","date":"2025-05-06","type":"pipeline","source":"The Chronicle-Journal","summary":"Silence Therapeutics Welcomes Tim McInerney to Board of Directors - The Chronicle-Journal","headline":"Silence Therapeutics Welcomes Tim McInerney to Board of Directors - The Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNNjN1RFdVaTE4cHJVUnBIaVJpVlBkOVhlSk9vb2FqT3A3UUtyU2UtdUJyLWJpYXZpZHc3YTd5YThCcUxXRjl3NjFudFNFdjYtSXhPd0hVclhSbUp1c2J3NDlyRExUNjhBREQ3WkFsQ3kwYlJzU3VjUHVPbDFDS25EVWRtSlpoQQ?oc=5","date":"2025-04-29","type":"pipeline","source":"Future Market Insights","summary":"AL Amyloidosis Therapeutics Market Size & Forecast 2025-2035 - Future Market Insights","headline":"AL Amyloidosis Therapeutics Market Size & Forecast 2025-2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQMzNXYTZadEEzT0p6NmFDWWhiRnNudWpoZVVLMEYzZ2xEYjFoMnBnS2Y5YkdHUzJhaUNtMU9ac05EOEx6OG1ST2plNC1TME42bGRETGk0OUlwV1lVXzdSSU9HSUloNnZHeUg4cEtEUnpad3ByZzVNb0E1ZUQ2N1hZb25DOU16VDZGWC0waWVsbDQzUmg0LVRSa2xRUEJkYklWRjlibWRwT1A1Umpwa3h2RkVTUmt1S0RaNXlPTWY3bm5ZaEFEMmc?oc=5","date":"2017-07-25","type":"deal","source":"PR Newswire","summary":"SOM Biotech Licenses its First Product and Expands to the United States - PR Newswire","headline":"SOM Biotech Licenses its First Product and Expands to the United States","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}